Latafix (Timolol Maleate, Latanoprost)

Timolol maleate blocks β‑adrenergic receptors in the eye, reducing the production of aqueous humor. Latanoprost activates prostaglandin F receptors, increasing uveoscleral outflow of fluid. Together, they provide a dual mechanism that effectively lowers eye pressure.

The dosing regimen for Latafix is determined by a qualified eye‑care professional. Typically, one drop is instilled in the affected eye(s) once daily, but the exact dose and frequency must be individualized by the prescriber based on the patient’s condition.

Safety data for Latafix in pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the treating physician.

To order Latafix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Latafix combines a beta‑blocker and a prostaglandin analog, offering a synergistic pressure‑lowering effect that can be more effective than using either class alone. Compared with monotherapy, the combination may reduce the need for multiple separate eye drops, improving adherence.

Latafix should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed when not in use and retain it in the original packaging to protect the formulation from contamination.

Latafix is applied as an ocular solution. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place one drop into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few seconds.

Serious adverse reactions include severe allergic responses such as swelling or anaphylaxis, significant bradycardia, bronchospasm in susceptible individuals, and intra‑ocular inflammation (iridocyclitis). Any of these symptoms require immediate medical attention.

Latafix is contraindicated in patients with known hypersensitivity to timolol, latanoprost, or any excipients in the formulation. It should also be avoided in individuals with severe asthma, certain cardiac conditions, or those using other beta‑blocker eye drops without medical supervision.